Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MCAC Panel Process Concerns Derail Ratification Of Initial Coverage Opinions

This article was originally published in The Gray Sheet

Executive Summary

Standard procedures for conducting Medicare Coverage Advisory Committee panel reviews must be developed if future panel recommendations are to hold any chance of ratification, several members of MCAC's Executive Committee maintained at a Dec. 8 meeting.

You may also be interested in...



Notice Of Intent Not A Part Of MCAC Executive Committee Meeting Agenda

The executive committee of the Medicare Coverage Advisory Committee likely will not discuss at its June 6 meeting the Health Care Financing Administration's recently released "notice of intent" on Medicare coverage criteria.

Notice Of Intent Not A Part Of MCAC Executive Committee Meeting Agenda

The executive committee of the Medicare Coverage Advisory Committee likely will not discuss at its June 6 meeting the Health Care Financing Administration's recently released "notice of intent" on Medicare coverage criteria.

MCAC Incontinence Panel Postponed; AMA Commends MCAC Executive Cmte.

The Health Care Financing Administration will postpone the next scheduled meeting of a Medicare Coverage Advisory Committee panel following recent comments made by the MCAC Executive Committee.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012707

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel